强生公司靶向tau蛋白抗体在阿尔茨海默病二期研究中失败
J&J’s tau-targeting antibody fails Phase 2 Alzheimer's study
#fails Phase#Alzheimer study#study Johnson#early-stage disease#promising candidates
生命科学资讯
生物技术与制药领域的最新动态
科伦药业TROP2 ADC联合Keytruda改善一线肺癌治疗效果
Kelun's TROP2 ADC plus Keytruda improves outcomes in first-line lung cancer
#first-line lung#lung cancer#cancer Merck#Keytruda improves#Chinese regulatory
Sarepta将向Arrowhead支付2亿美元里程碑款项；Enlivex公布骨关节炎数据
Sarepta to pay $200M milestone to Arrowhead; Enlivex reports osteoarthritis data
#Clearside Biomedical#MindImmune Therapeutics#Enlivex reports#pay Arrowhead#continues type
百健与新创公司Dayra Therapeutics达成免疫炎症领域合作协议，后者为Versant旗下大环化合物研发企业。
Biogen pens I&I deal with new Versant macrocycle developer Dayra Therapeutics
#Versant Ventures’#Dayra Therapeutics#Ventures’ latest#Therapeutics Versant#Versant macrocycle
拜耳股价因新一代血液稀释剂三期试验成功逆势上扬。
Bayer’s stock rallies as next-gen blood thinner beats the odds with Phase 3 win
#win Bayer#high-profile failures#stock rallies#next-gen blood#blood thinner
诺和诺德公司的司美格鲁肽在备受关注的阿尔茨海默病试验中未达预期
Novo Nordisk's semaglutide misses in closely-watched Alzheimer’s trials
#Novo Nordisk#closely-watched Alzheimer#long shot#long shots#Nordisk semaglutide
克雷格·克鲁斯与米凯尔·多尔斯坦为采石场疗法公司筹集3200万美元
Craig Crews, Mikael Dolsten raise $32M for Quarry Thera
#Mikael Dolsten#Quarry Thera#Craig Crews#Dolsten raise#Mikael
诺贝尔奖得主卡罗琳·贝尔托齐将重返礼来董事会
Nobel laureate Carolyn Bertozzi to rejoin Lilly board
#Carolyn Bertozzi#Eli Lilly#SEC filing#Friday evening#evening SEC
马卡里用户收费言论；并购热潮持续；基因编辑新用途探索及其他动态
Makary’s user fee comments; M&A activity stays hot; A new use for prime editing; and more
#Endpoints Weekly#fee comments#stays hot#prime editing#user fee
白宫反对后，马卡里高级助手杰恩-纳格帕尔仍留任FDA
Top Makary aide Jain-Nagpal remains at the FDA after White House pushback
#White House#Commissioner Marty#FDA Commissioner#Marty Makary#Top Makary
阿斯利康将罕见病药物组合本土化，作为其向美国承诺的500亿美元投资的一部分。
AstraZeneca to onshore rare disease portfolio as part of its $50B pledge to the US
#announced Friday#billion pledge#onshore rare#rare disease#disease portfolio
梯瓦制药在华盛顿联邦法院对IRA药品定价法案的挑战败诉
Teva loses IRA drug pricing challenge in DC federal court
#federal court#loses IRA#IRA drug#Medicare negotiations#pharma industry
Sarepta与Hansa合作终止Elevidys试验前处理；Moderna部分管线项目遭削减。
Sarepta ends Elevidys trial with Hansa's pre-treatment; Some pipeline cuts at Moderna
#Blue Lake#Inhibikase Therapeutics#Olema Oncology#Elevidys trial#Hansa Biopharma
美国FDA调查可能与武田酶替代疗法相关的儿童死亡事件
FDA investigates child death potentially related to Takeda's enzyme replacement therapy
#FDA investigates#blood disorder#Takeda enzyme#potentially related#investigates child
诺和、礼来开始直接向雇主销售减肥药物
Novo, Lilly begin to sell obesity medications directly to employers
#Novo Nordisk#Eli Lilly#employers Building#Lilly begin#weight loss
礼来成为首家市值破万亿美元的制药公司
Lilly becomes first $1 trillion pharma company
#Eli Lilly#company Eli#Lilly market#pharma company#briefly reached
Contineum与强生合作药物在多发性硬化症二期试验中失败
Contineum's J&J-partnered drug fails Phase 2 multiple sclerosis trial
#Thursday afternoon#fails Phase#Therapeutics reported#multiple sclerosis#J-partnered drug
葛兰素史克与阿纳普蒂生物就十年期Jemperli许可协议对簿公堂
GSK, AnaptysBio enter legal battle over decade-old Jemperli licensing deal
#decade-old Jemperli#drug Jemperli#Jemperli licensing#subsidiary Tesaro#cancer drug
杰夫·布鲁斯通与斯蒂芬·迪利探讨CEO交接及索诺玛未来走向；斯科特·戈特利布的下一步动向
Jeff Bluestone, Stephen Dilly talk CEO handoff, what’s next for Sonoma; Scott Gottlieb's next move
#Stephen Dilly#Scott Gottlieb#Jeff Bluestone#Sonoma Biotherapeutics#CEO handoff
在RFK Jr.影响下，疫苗接种率下滑，公众疑虑加剧
Under RFK Jr., vaccine use slides while suspicion rises
#vaccine revenue#suspicion rises#flu season#federal health#health officials